Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| YEASEN Biotechnology | 2021 | Series B | $38.8M | Shanghai |
| RecBio | 2021 | Series C | $156.3M | Taizhou |
| Feiyu | 2021 | Series B | $30.0M | Jiading |
| GensKey | 2021 | Series C | $15.7M | Beijing |
| Bloks Technology Group | 2021 | Series B | $93.2M | Minhang |
| Shanghai Cell Therapy Group | 2021 | Series D | $76.6M | Jiading |
| Exegenesis Bio | 2021 | Series B | Undisclosed | Lansdale |
| Hongshan Information Technology | 2021 | Series Unknown | Undisclosed | Beijing |
| Urotronic | 2020 | Series C | $20.0M | Minneapolis |
| Tongcheng Shenghuo | 2020 | Series C | Undisclosed | Suzhou |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 126 | YEASEN Biotechnology | Series B | $38.8M | Shanghai, China |
| 127 | RecBio | Series C | $156.3M | Taizhou, China |
| 128 | Feiyu | Series B | $30.0M | Jiading, China |
| 129 | GensKey | Series C | $15.7M | Beijing, China |
| 130 | Bloks Technology Group | Series B | $93.2M | Minhang, China |
| 131 | Shanghai Cell Therapy Group | Series D | $76.6M | Jiading, China |
| 132 | Exegenesis Bio | Series B | Undisclosed | Lansdale, United States |
| 133 | Hongshan Information Technology | Series Unknown | Undisclosed | Beijing, China |
| 134 | Urotronic | Series C | $20.0M | Minneapolis, United States |
| 135 | Tongcheng Shenghuo | Series C | Undisclosed | Suzhou, China |
YEASEN commitment to developing and producing enzyme products.
Focusing on major innovative vaccines with independent intellectual property rights.
Feiyu is an online purchasing platform for luxury trading bags.
GensKey is a genetic testing medical diagnostic service provider
Bloks Group uses innovative technology to create the ultimate product experience and create long-term value for users.
Shanghai Cell Therapy Group is a provider of cellular diagnosis center combining cellular research and treatment services.
Exegenesis Bio is a Gene therapy start-up.
Hongshan Information Technology is a 5G and future ICT developers
Urotronic is a medical device company that develops a drug-coated balloon device for interventional urology.
Tongcheng Shenghuo is a community O2O group purchase service platform.
Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs.
New Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.
Mancando is an automotive parts supplier company that provides car wearing parts for auto repair factory.
iBeiDiao is an intelligent employee background investigation service providing platform.
ANYCOLOR is an entertainment startup that is engaged in overseas VTuber business and new businesses.
C Channel is an online video-based digital fashion media platform.
VDN Cloud is a provider of cloud and edge computing services.
Berry Genomics is a company specializing in developing and commercializing technologies for life sciences and clinical applications.
Feima Robotics is an IT company that develops UAV software and hardware integration solutions and provides spatial data system services.
PhiSkin is a minimal invasive medical aesthetic clinics chain in China.
Chaodian Culture is a brokerage firm that provides in cultural brand of the bilibili video screen network.
Santouliubi is an enterprise cloud communication services provider company.
Yungehuo is a Logistics company.
Jollychic is an e-commerce platform that sells clothing and accessories online.
Jiangrongxin Technology is a Developer of financial and marketing software for consumer financial services enterprises.
Legend Capital has invested in 203 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Legend Capital's top investment sectors include Health Care, Biotechnology, Information Technology, Medical, E-Commerce. The firm invests across 52 different industry categories.
Among tracked funding rounds, Haihe Biopharma received $171.0M in a Series B round. Legend Capital's total known invested capital is $4.9B.
Legend Capital's average investment size is $37.7M across its portfolio of 203 companies.
Recent Legend Capital portfolio additions include YEASEN Biotechnology, RecBio, Feiyu, GensKey, Bloks Technology Group. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors